Actualités

The law, which would prohibit PBM conglomerates from owning or operating pharmacies, illegally boots out-of-state companies from Tennessee’s pharmacy market, CVS argued in a suit filed Friday.

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.61%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.76%. June E-mini S&P futures (ESM26 ) rose +0.61%, and June E-mini Nasdaq futures...

The S&P 500 Index ($SPX ) (SPY ) today is up +0.81%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.74%. June E-mini S&P futures (ESM26 ) are up +0.77%, and June E-mini Nasdaq futures...

CVS Health Corporation (NYSE:CVS) is one of the best medical stocks to invest in according to billionaires. Morgan Stanley lifted the price target on CVS Health Corporation (NYSE:CVS) to $106 from $93 on May 14, maintaining an Overweight rating on the shares. CVS Health Corporation (NYSE:CVS) also received a rating update from Bernstein on May 13, […]

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.

With an annual dividend yield of 2.84%, CVS Health Corporation (NYSE:CVS) is included among the 12 Best Dividend Stocks to Invest in According to Hedge Funds. America’s leading health solutions company, CVS Health Corporation (NYSE:CVS) provides advanced health care from pharmacy services and health plans to health and wellness. On May 20, Mizuho bumped up its price […]

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

CVS sued Tennessee after Gov. Bill Lee signed legislation to prohibit companies from owning both pharmacy benefit managers and retail pharmacies.

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

CVS Health Corporation (NYSE:CVS) is included among the 10 High Quality Stocks to Buy According to Hedge Funds. On May 13, Bernstein raised its price recommendation on CVS Health Corporation (NYSE:CVS) to $106 from $94. It reiterated an Outperform rating on the stock. The firm said it still sees CVS as well-positioned to benefit from […]

Hospitals affiliated with Mount Sinai, the University of Michigan and the University of Kansas allege that CVS artificially deflated reimbursement for 340B drugs for years, causing them to lose out on savings.

Three major hospital systems have accused CVS of allegedly diverting hundreds of millions from the federal 340B Drug Pricing Program.

Don’t be surprised if you see more jewelry or hair accessories during your next trip to CVS, Walmart, or Kohl’s.

CVS Health (NYSE:CVS) has been hit with two lawsuits from major hospital systems tied to the federal 340B drug discount program. The University of Kansas Hospital Authority and the University of Michigan Hospitals and Health Centers allege CVS Health improperly profited from 340B discounts. Combined claimed damages exceed $60 million, raising legal, financial, and reputational questions for the company. CVS Health comes into this legal pressure with its shares at $93.28 and a return of...

Claire's filed for Chapter 11 bankruptcy in August 2025, the chain's second bankruptcy filling in seven years.

DHR's Biotechnology segment posts 7% core revenue growth as bioprocessing demand stayed strong and equipment orders jumped despite headwinds.

CVS is more than a dividend play.

Takeda confirmed it would appeal the outcome, stating that the case “lacks merit”.

The president’s financial disclosures reveal several trades in UnitedHealth and other insurers as the government set Medicare rate policies.

Looking past stocks because they trade at high trailing earnings multiples can be a costly mistake for investors.

Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution. They negotiate rebates, design formularies, adjudicate claims, and steer patient adherence. Modern artificial intelligence (AI) is designed to compress each of these high-volume, rules-driven processes. As autonomous prior authorization, real-time formulary optimization, and AI-driven rebate analytics scale, the Big Three PBMs face a ... AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

A licensing agreement with Centric Brands will scale the retailer’s presence across partners, including Walmart, Kohl’s and CVS and will push the brand into new categories.

Over the past year, many CVS Health Corporation ( NYSE:CVS ) insiders sold a significant stake in the company which may...

We recently published Jim Cramer’s Latest Thoughts On Cisco, NVIDIA & Other AI Stocks. CVS Health Corp. (NYSE:CVS) is one the stocks discussed by Jim Cramer. Health insurer CVS Health Corp. (NYSE:CVS) is another stock that popped on Jim Cramer’s radar. The shares are up by 58.6% over the past year and by 19.7% year-to-date. […]

CVS Health’s first quarter results drew a significant positive market reaction, with performance driven by disciplined cost management, margin expansion, and continued improvement at Aetna. Management credited strong execution in medical cost containment and operational streamlining, particularly within the Health Care Benefits segment, as key factors. CEO David Joyner stated, “We are driving improved results at Aetna, while removing friction for members and providers.” Pharmacy & Consumer Welln

CVS Health (NYSE:CVS) has agreed to sell its Omnicare long-term care pharmacy business to GenieRx Holdings, with the transaction now approved. The company has also introduced CVS Air Response, a drone-enabled healthcare logistics and emergency support network built with SkyfireAI and Thales Aerospace. These moves reflect a refocus on core operations and new delivery channels for pharmacy and healthcare services. For investors tracking NYSE:CVS, these announcements come alongside recent...

Our 24/7 Wall St. price target for CVS Health (NYSE:CVS) is $125.45, pointing to meaningful upside from where shares trade today. The stock closed at $86.86 on May 6, after a 7.65% single-day pop on Q1 earnings. Our model implies 44.43% upside over the next 12 months, and we are issuing a buy rating with ... Price Prediction: CVS Eyes 44% Upside After Aetna-Driven Q1 Surge

CVS Health Corp. (NYSE:CVS) is one of the cheap stocks to buy for the next 10 years. On May 6, CVS Health Corporation reported Q1 2026 results, with total revenues increasing 6.2% year-over-year to $100.4 billion. The company achieved a GAAP diluted EPS of $2.30 and an Adjusted EPS of $2.57, up from $1.41 and […]